Abstract
In this chapter, we describe the potential for drug interactions for various antimalarial drugs based on their known metabolic properties. These antimalarials include the following: chloroquine, amodiaquine, sulfadoxine and pyrimethamine, mefloquine, primaquine, atovaquone, proguanil, quinine, artemisinin, artesunate, artemether, and dihydroartemisin.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bapiro TE, Egnell AC, Hasler JA et al (2001) Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. Drug Metab Dispos 29(1):30–35
Birkett DJ, Rees D, Andersson T et al (1994) In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase. Br J Clin Pharmacol 37(5):413–420
Coller JK, Somogyi AA, Bochner F (1999) Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms. Br J Clin Pharmacol 48(2):158–167
Elsherbiny DA, Asimus SA, Karlsson MO et al (2008) A model based assessment of the CYP2B6 and CYP2C19 inductive properties by artemisinin antimalarials: implications for combination regimens. J Pharmacokinet Pharmacodyn 35(2):203–217
Fontaine F, Delescluse C, de Sousa G et al (1999) Cytochrome P450 1A1 induction by primaquine in human hepatocytes and HepG2 cells: absence of binding to the aryl hydrocarbon receptor. Biochem Pharmacol 57:255–262
Fontaine F, de Sousa G, Burcham PC et al (2000) Role of cytochrome P450 3A in the metabolism of mefloquine in human and animal hepatocytes. Life Sci 66(22):2193–2212
Grace JM, Aguilar AJ, Trotman KM et al (1998) Metabolism of beta-arteether to dihydroqinghaosu by human liver microsomes and recombinant cytochrome P450. Drug Metab Dispos 26(4):313–317
Ilett KF, Ethell BT, Maggs JL et al (2002) Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases. Drug Metab Dispos 30(9):1005–1012
Jin X, Pybus BS, Marcsisin SR et al (2014) An LC-MS based study of the metabolic profile of primaquine, an 8-aminoquinoline antiparasitic drug, with an in vitro primary human hepatocyte culture model. Eur J Drug Metab Pharmacokinet 39(2):139–146
Kim KA, Park JY, Lee JS et al (2003) Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes. Arch Pharm Res 26(8):631–637
Li XQ, Bjorkman A, Andersson TB, Ridderstrom M et al (2002) Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate. J Pharmacol Exp Ther 300(2):399–407
Li XQ, Bjorkman A, Andersson TB et al (2003) Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. Eur J Clin Pharmacol 59:429–442
Lu AH, Shu Y, Huang SL (2000) In vitro proguanil activation to cycloguanil is mediated by CYP2C19 and CYP3A4 in adult Chinese liver microsomes. Acta Pharmacol Sin 21(8):747–752
Masimirembwa CM, Hasler JA, Johansson I (1995) Inhibitory effects of antiparasitic drugs on cytochrome P450 2D6. Eur J Clin Pharmacol 48(1):35–38
Na-Bangchang K, Karbwang J, Back DJ (1992) Mefloquine metabolism by human liver microsomes. Effect of other antimalarial drugs. Biochem Pharmacol 43(9):1957–1961
Parikh S, Ouedraogo JB, Goldstein JA et al (2007) Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa. Clin Pharmacol Ther 82(2):197–203
Projean D, Baune B, Farinotti R et al (2003) In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation. Drug Metab Dispos 31(6):748–754
Rolan PE, Mercer AJ, Tate E et al (1997) Disposition of atovaquone in humans. Antimicrob Agents Chemother 41(6):1319–1321
Simonsson US, Jansson B, Hai TN et al (2003) Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9. Clin Pharmacol Ther 74(1):32–43
Svensson US, Ashton M (1999) Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin. Br J Clin Pharmacol 48(4):528–535
Svensson US, Ashton M, Trinh NH et al (1998) Artemisinin induces omeprazole metabolism in human beings. Clin Pharmacol Ther 64(2):160–167
Trapnell CB, Klecker RW, Jamis-Dow C et al (1998) Glucuronidation of 3′-azido-3′-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid. Antimicrob Agents Chemother 42(7):1592–1596
Walsky RL, Obach RS, Gaman EA et al (2005) Selective inhibition of human cytochrome P4502C8 by montelukast. Drug Metab Dispos 33(3):413–418
Zhao XJ, Ishizaki T (1997) Metabolic interactions of selected antimalarial and non-antimalarial drugs with the major pathway (3-hydroxylation) of quinine in human liver microsomes. Br J Clin Pharmacol 44(5):505–511
Zhao XJ, Ishizaki T (1999) A further interaction study of quinine with clinically important drugs by human liver microsomes: determinations of inhibition constant (Ki) and type of inhibition. Eur J Drug Metab Pharmacokinet 24(3):272–278
Zhao XJ, Yokoyama H, Chiba K et al (1996) Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450. J Pharmacol Exp Ther 279(3):1327–1334
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Kiang, T.K.L., Wilby, K.J., Ensom, M.H.H. (2015). Drug Interaction Potential of Antimalarial Drugs Based on Known Metabolic Properties of Antimalarials. In: Clinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials. Adis, Cham. https://doi.org/10.1007/978-3-319-10527-7_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-10527-7_3
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-10526-0
Online ISBN: 978-3-319-10527-7
eBook Packages: MedicineMedicine (R0)